HSBC Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$190M Sell
362,124
-27,474
-7% -$14.4M 0.11% 150
2025
Q1
$247M Sell
389,598
-44,206
-10% -$28M 0.15% 115
2024
Q4
$309M Buy
433,804
+76,720
+21% +$54.6M 0.18% 84
2024
Q3
$375M Sell
357,084
-8,841
-2% -$9.28M 0.22% 71
2024
Q2
$384M Sell
365,925
-11,501
-3% -$12.1M 0.23% 71
2024
Q1
$363M Buy
377,426
+52,414
+16% +$50.4M 0.25% 70
2023
Q4
$286M Buy
325,012
+56,010
+21% +$49.2M 0.25% 65
2023
Q3
$221M Sell
269,002
-33,661
-11% -$27.7M 0.23% 68
2023
Q2
$217M Buy
302,663
+46,863
+18% +$33.6M 0.22% 81
2023
Q1
$210M Sell
255,800
-1,805
-0.7% -$1.48M 0.25% 70
2022
Q4
$186M Buy
257,605
+71,846
+39% +$51.7M 0.21% 82
2022
Q3
$128M Buy
185,759
+28,396
+18% +$19.6M 0.21% 74
2022
Q2
$93.5M Buy
157,363
+66,224
+73% +$39.4M 0.13% 119
2022
Q1
$63.5M Sell
91,139
-5,791
-6% -$4.03M 0.08% 222
2021
Q4
$61.8M Sell
96,930
-22,829
-19% -$14.6M 0.06% 278
2021
Q3
$72.6M Sell
119,759
-11,919
-9% -$7.22M 0.07% 208
2021
Q2
$73M Sell
131,678
-134,728
-51% -$74.7M 0.08% 214
2021
Q1
$126M Buy
266,406
+139,352
+110% +$65.8M 0.15% 111
2020
Q4
$60.9M Buy
127,054
+48,443
+62% +$23.2M 0.08% 214
2020
Q3
$44.7M Buy
78,611
+3,255
+4% +$1.85M 0.07% 228
2020
Q2
$47M Buy
75,356
+4,657
+7% +$2.9M 0.09% 182
2020
Q1
$34.1M Sell
70,699
-18,539
-21% -$8.94M 0.08% 217
2019
Q4
$33.4M Sell
89,238
-6,303
-7% -$2.36M 0.06% 285
2019
Q3
$26.5M Buy
95,541
+10,310
+12% +$2.86M 0.05% 316
2019
Q2
$26.7M Buy
85,231
+27,064
+47% +$8.47M 0.05% 305
2019
Q1
$23.9M Buy
58,167
+5,895
+11% +$2.42M 0.04% 339
2018
Q4
$19.5M Sell
52,272
-7,190
-12% -$2.68M 0.04% 358
2018
Q3
$24M Buy
59,462
+13,914
+31% +$5.62M 0.04% 369
2018
Q2
$15.7M Sell
45,548
-26,891
-37% -$9.28M 0.03% 468
2018
Q1
$24.9M Sell
72,439
-79,994
-52% -$27.5M 0.04% 390
2017
Q4
$57.3M Buy
152,433
+107,783
+241% +$40.5M 0.08% 214
2017
Q3
$20M Sell
44,650
-17,998
-29% -$8.05M 0.03% 431
2017
Q2
$30.8M Sell
62,648
-623
-1% -$306K 0.06% 294
2017
Q1
$24.5M Sell
63,271
-1,261
-2% -$488K 0.05% 344
2016
Q4
$23.7M Buy
64,532
+10,406
+19% +$3.82M 0.06% 313
2016
Q3
$21.8M Buy
54,126
+7,822
+17% +$3.15M 0.05% 316
2016
Q2
$16.2M Sell
46,304
-7,522
-14% -$2.63M 0.04% 373
2016
Q1
$19.4M Buy
53,826
+1,991
+4% +$717K 0.05% 350
2015
Q4
$28.2M Sell
51,835
-15,202
-23% -$8.26M 0.07% 271
2015
Q3
$31.1M Sell
67,037
-29,335
-30% -$13.6M 0.08% 261
2015
Q2
$49.1M Sell
96,372
-1,378
-1% -$702K 0.1% 198
2015
Q1
$44.2M Buy
97,750
+9,700
+11% +$4.39M 0.08% 225
2014
Q4
$36.1M Buy
88,050
+17,850
+25% +$7.32M 0.07% 241
2014
Q3
$25.3M Buy
70,200
+11,199
+19% +$4.03M 0.05% 324
2014
Q2
$16.6M Sell
59,001
-16,284
-22% -$4.59M 0.04% 402
2014
Q1
$22.6M Buy
75,285
+11,973
+19% +$3.6M 0.05% 319
2013
Q4
$17.4M Buy
63,312
+14,089
+29% +$3.88M 0.05% 353
2013
Q3
$15.3M Buy
49,223
+14,998
+44% +$4.67M 0.04% 378
2013
Q2
$7.7M Buy
+34,225
New +$7.7M 0.02% 509